Approval · Notice of Compliance 24535 · 2020
LONSURF: Notice of Compliance 24535
Issued November 3, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24535
- Date
- November 3, 2020
- Company
- Taiho Pharma Canada, Inc.Oakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the product monograph and alternate dosing for severe renal impairment patients
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LONSURF | Not yet assigned | — |
Medicinal ingredients
- TRIFLURIDINE 15 MG per TAB
- TIPIRACIL HYDROCHLORIDE 6.14 MG per TAB
- TRIFLURIDINE 20 MG per TAB
- TIPIRACIL HYDROCHLORIDE 8.19 MG per TAB